# Playbook - PET / NM Substance Given

**URL:** <https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151>\
**Category:** radiology\
**Created:** [April 12, 2022, 5:22am UTC](https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151 "2022-04-12T05:22:52Z")\
**Posts on this page:** 4\
**Page:** 1

<div class="post-metadata">

**Author:** ![batistad](https://forum.loinc.org/letter_avatar_proxy/v4/letter/b/94ad74/32.png) [@batistad](https://forum.loinc.org/u/batistad)\
**Post date:** [April 12, 2022, 5:22am UTC](https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151/1 "2022-04-12T05:22:52Z")

</div>

\<p class=“MsoNormal”\>\<a name=“OLE\_LINK1”\>\</a\>\<span lang=“FR” style=“mso-ansi-language: FR;”\>Hello,\</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>When looking specifically at PET / NM entries of the playbook, I came across some inconsistencies. Namely, some procedures don’t have a Rad.Pharmaceutical.Substance Given part. It happens even for some procedures where the substance is explicit in the name (e.g. In-111). Either way, shouldn’t all these procedures have at least LP208665-2 (Radionuclide)?\</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>Here is the list of procedures:\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpFirst” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>24770-0 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Joint Views W In-111 intrajoint\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>25032-4 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Bone Views W In-111 tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>39666-3 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Heart Views W stress and W 201 Th IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>39848-7 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Head to Pelvis Views for shunt patency W In-111 IT\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>41772-5 ,\<span style=“mso-spacerun: yes;”\> \</span\>SPECT Bone W In-111 tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>41836-8 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Bone Limited Views W In-111 tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>42711-2 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Whole body Views W In-111 tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>43459-7 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Brain Views during electroconvulsive shock treatment\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>43562-8 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Skeletal system.axial Views for bone density\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>43563-6 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Skeletal system.peripheral Views for bone density\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>44140-2 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Abdomen and Pelvis Views for tumor\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81548-0 ,\<span style=“mso-spacerun: yes;”\> \</span\>SPECT Unspecified body region W tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81557-1 ,\<span style=“mso-spacerun: yes;”\> \</span\>SPECT Brain W florbetapir IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81568-8 ,\<span style=“mso-spacerun: yes;”\> \</span\>PT perfusion Heart W multiple states of exercise\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81569-6 ,\<span style=“mso-spacerun: yes;”\> \</span\>PT perfusion Heart W single state of exercise\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81584-5 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Whole body Views W tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81585-2 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Unspecified body region Views W tagged WBC IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81597-7 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Bones Views for metastasis W Ra-223 IV\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81609-0 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Liver Views W SIR-spheres intraarterial hepatic injection\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpMiddle” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>81610-8 ,\<span style=“mso-spacerun: yes;”\> \</span\>NM Liver Views W Theraspheres intraarterial hepatic injection\</span\>\</p\>  
\<p class=“MsoListParagraphCxSpLast” style=“text-indent: -.25in; mso-list: l0 level1 lfo1;”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>\<!-- [if !supportLists]–\>\<span style=“font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;”\>\<span style=“mso-list: Ignore;”\>·\<span style=“font: 7.0pt ‘Times New Roman’;”\> \</span\>\</span\>\</span\>\<!–[endif]–\>82126-4 ,\<span style=“mso-spacerun: yes;”\> \</span\>PT Guidance for radiation treatment of Unspecified body region\</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\> \</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>I was also wondering about the strategy to specify tagged WBC. Would this be included in the substance given, as is the case for Tc-99m tagged RBC?\</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>Thank you for your help understanding these issues.\</span\>\</p\>  
\<p class=“MsoNormal”\>\<span style=“mso-bookmark: OLE\_LINK1;”\>Best regards,\</span\>\</p\>

---

<div class="post-metadata">

**Author:** ![batistad](https://forum.loinc.org/letter_avatar_proxy/v4/letter/b/94ad74/32.png) [@batistad](https://forum.loinc.org/u/batistad)\
**Post date:** [April 12, 2022, 5:56am UTC](https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151/2 "2022-04-12T05:56:50Z")

</div>

![]()

---

<div class="post-metadata">

**Author:** ![batistad](https://forum.loinc.org/letter_avatar_proxy/v4/letter/b/94ad74/32.png) [@batistad](https://forum.loinc.org/u/batistad)\
**Post date:** [April 12, 2022, 6:08am UTC](https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151/3 "2022-04-12T06:08:29Z")

</div>

![]()

&nbsp;

---

<div class="post-metadata">

**Author:** ![system](https://forum.loinc.org/uploads/default/original/1X/dbab97ce9b2987d788a376e254fcaae249f3b672.png) [@system](https://forum.loinc.org/u/system)\
**Post date:** [June 23, 2023, 3:36pm UTC](https://forum.loinc.org/t/playbook-pet-nm-substance-given/1151/4 "2023-06-23T15:36:50Z")

</div>

Closed on June 23, 2023, 3:36pm UTC


